Double-Blind Placebo Controlled, Cross-over Trial of Subcutaneous B12 on Behavioral and Metabolic Measures in Children With Autism. View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2005-2009

ABSTRACT

We will be testing a specific dietary supplement, methylcobalamin (vitamin B12). Follow-up assessments with our clinical team will take place over the 12-week study period so that we can record any changes in development. The main goal of this study is to determine if subcutaneous injections of vitamin B12 given every three days can positively affect behavior and development in children with autism. Hypothesis: Methylcobalamin injections will improve measures of executive function, speech, and socialization in children with autism, and will be associated with metabolic improvement. Detailed Description Autism is a complex neurodevelopmental disorder that is thought to involve an interaction between multiple and variable susceptibility genes (Keller & Persico, 2003), epigenetic effects (Beaudet, 2002), and environmental factors (London, 2000). The increase in the prevalence of autistic spectrum disorders from 4-5/10,000 in the 1980s to 30-60/10,000 in the last decade has raised great concern (Bertrand et al., 2001; DeStefano et al., 2004; Steinhausen et al., 1986; Yeargin-Allsopp et al., 2003). Research into potential therapeutic interventions designed to ameliorate the metabolic and clinical symptoms of autism is urgently needed to reduce the enormous public health burden of this disorder and to improve the quality of life for affected children and their families. Nutritional supplementation through subcutaneous injections of methyl B12 is a current treatment for children with autism that has anecdotal reports of remarkable clinical improvements and few side effects. However there are no published studies to support its clinical benefit. Comparison: Injections of methylcobalamin compared to injections of sterile saline over a six week period. More... »

URL

https://clinicaltrials.gov/show/NCT00273650

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "We will be testing a specific dietary supplement, methylcobalamin (vitamin B12). Follow-up assessments with our clinical team will take place over the 12-week study period so that we can record any changes in development. The main goal of this study is to determine if subcutaneous injections of vitamin B12 given every three days can positively affect behavior and development in children with autism. Hypothesis: Methylcobalamin injections will improve measures of executive function, speech, and socialization in children with autism, and will be associated with metabolic improvement.\n\nDetailed Description\nAutism is a complex neurodevelopmental disorder that is thought to involve an interaction between multiple and variable susceptibility genes (Keller & Persico, 2003), epigenetic effects (Beaudet, 2002), and environmental factors (London, 2000). The increase in the prevalence of autistic spectrum disorders from 4-5/10,000 in the 1980s to 30-60/10,000 in the last decade has raised great concern (Bertrand et al., 2001; DeStefano et al., 2004; Steinhausen et al., 1986; Yeargin-Allsopp et al., 2003). Research into potential therapeutic interventions designed to ameliorate the metabolic and clinical symptoms of autism is urgently needed to reduce the enormous public health burden of this disorder and to improve the quality of life for affected children and their families. Nutritional supplementation through subcutaneous injections of methyl B12 is a current treatment for children with autism that has anecdotal reports of remarkable clinical improvements and few side effects. However there are no published studies to support its clinical benefit. Comparison: Injections of methylcobalamin compared to injections of sterile saline over a six week period.", 
    "endDate": "2009-08-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT00273650", 
    "keywords": [
      "anecdotal report", 
      "affected child", 
      "life", 
      "environmental factor", 
      "neurodevelopmental disorder", 
      "published study", 
      "B12", 
      "disorder", 
      "IN", 
      "child", 
      "main goal", 
      "clinical improvement", 
      "Vitamin B 12", 
      "saline", 
      "development", 
      "period", 
      "side effect", 
      "speech", 
      "behavior", 
      "family", 
      "study period", 
      "comparison", 
      "clinical symptom", 
      "Weight and Measure", 
      "double blind placebo", 
      "clinical benefit", 
      "Autistic Disorder", 
      "clinical team", 
      "autistic spectrum disorder", 
      "subcutaneous injection", 
      "enormous public health burden", 
      "injection", 
      "Cross-Over Study", 
      "Keller", 
      "London", 
      "last decade", 
      "nutritional supplementation", 
      "executive function", 
      "follow-up assessment", 
      "improvement", 
      "socialization", 
      "epigenetic effect", 
      "current treatment", 
      "methyl", 
      "susceptibility gene", 
      "potential therapeutic intervention", 
      "dietary supplement", 
      "great concern", 
      "prevalence"
    ], 
    "name": "Double-Blind Placebo Controlled, Cross-over Trial of Subcutaneous B12 on Behavioral and Metabolic Measures in Children With Autism.", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT00273650"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00002.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.27860.3b", 
        "type": "Organization"
      }
    ], 
    "startDate": "2005-07-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "https://doi.org/10.1097/00004703-200312000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001210734"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1054/plef.2002.0439", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001238276"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1385/mn:28:1:1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002335812", 
          "https://doi.org/10.1385/mn:28:1:1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0009-8981(03)00119-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003671531"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/bbrc.1999.0696", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007204574"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1432-1327.2000.01595.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011567592"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10803-004-2549-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032339104", 
          "https://doi.org/10.1007/s10803-004-2549-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10803-004-2549-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032339104", 
          "https://doi.org/10.1007/s10803-004-2549-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0165-1781(03)00200-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037342731"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ridd.2004.09.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037628793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-7138(09)60225-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047880200"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1097/00125817-200209000-00013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049523611", 
          "https://doi.org/10.1097/00125817-200209000-00013"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.289.1.49", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053720106"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-2000-8466", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057404548"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/321262", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058623432"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1289/ehp.00108s3401", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064737166"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1289/ehp.00108s3401", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064737166"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1542/peds.108.5.1155", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067821287"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1542/peds.113.2.259", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067822486"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075245451", 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT00273650"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT00273650'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT00273650'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT00273650'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT00273650'


 

This table displays all metadata directly associated to this object as RDF triples.

124 TRIPLES      16 PREDICATES      82 URIs      58 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT00273650 schema:about anzsrc-for:3053
2 schema:description We will be testing a specific dietary supplement, methylcobalamin (vitamin B12). Follow-up assessments with our clinical team will take place over the 12-week study period so that we can record any changes in development. The main goal of this study is to determine if subcutaneous injections of vitamin B12 given every three days can positively affect behavior and development in children with autism. Hypothesis: Methylcobalamin injections will improve measures of executive function, speech, and socialization in children with autism, and will be associated with metabolic improvement. Detailed Description Autism is a complex neurodevelopmental disorder that is thought to involve an interaction between multiple and variable susceptibility genes (Keller & Persico, 2003), epigenetic effects (Beaudet, 2002), and environmental factors (London, 2000). The increase in the prevalence of autistic spectrum disorders from 4-5/10,000 in the 1980s to 30-60/10,000 in the last decade has raised great concern (Bertrand et al., 2001; DeStefano et al., 2004; Steinhausen et al., 1986; Yeargin-Allsopp et al., 2003). Research into potential therapeutic interventions designed to ameliorate the metabolic and clinical symptoms of autism is urgently needed to reduce the enormous public health burden of this disorder and to improve the quality of life for affected children and their families. Nutritional supplementation through subcutaneous injections of methyl B12 is a current treatment for children with autism that has anecdotal reports of remarkable clinical improvements and few side effects. However there are no published studies to support its clinical benefit. Comparison: Injections of methylcobalamin compared to injections of sterile saline over a six week period.
3 schema:endDate 2009-08-01T00:00:00Z
4 schema:keywords Autistic Disorder
5 B12
6 Cross-Over Study
7 IN
8 Keller
9 London
10 Vitamin B 12
11 Weight and Measure
12 affected child
13 anecdotal report
14 autistic spectrum disorder
15 behavior
16 child
17 clinical benefit
18 clinical improvement
19 clinical symptom
20 clinical team
21 comparison
22 current treatment
23 development
24 dietary supplement
25 disorder
26 double blind placebo
27 enormous public health burden
28 environmental factor
29 epigenetic effect
30 executive function
31 family
32 follow-up assessment
33 great concern
34 improvement
35 injection
36 last decade
37 life
38 main goal
39 methyl
40 neurodevelopmental disorder
41 nutritional supplementation
42 period
43 potential therapeutic intervention
44 prevalence
45 published study
46 saline
47 side effect
48 socialization
49 speech
50 study period
51 subcutaneous injection
52 susceptibility gene
53 schema:name Double-Blind Placebo Controlled, Cross-over Trial of Subcutaneous B12 on Behavioral and Metabolic Measures in Children With Autism.
54 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT00273650
55 schema:sdDatePublished 2019-03-07T15:21
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher Nb80c361c65ce4bb992ae392fd3ae18e4
58 schema:sponsor https://www.grid.ac/institutes/grid.27860.3b
59 schema:startDate 2005-07-01T00:00:00Z
60 schema:subjectOf sg:pub.10.1007/s10803-004-2549-6
61 sg:pub.10.1097/00125817-200209000-00013
62 sg:pub.10.1385/mn:28:1:1
63 https://app.dimensions.ai/details/publication/pub.1075245451
64 https://doi.org/10.1001/jama.289.1.49
65 https://doi.org/10.1006/bbrc.1999.0696
66 https://doi.org/10.1016/j.ridd.2004.09.002
67 https://doi.org/10.1016/s0002-7138(09)60225-9
68 https://doi.org/10.1016/s0009-8981(03)00119-0
69 https://doi.org/10.1016/s0165-1781(03)00200-2
70 https://doi.org/10.1046/j.1432-1327.2000.01595.x
71 https://doi.org/10.1054/plef.2002.0439
72 https://doi.org/10.1055/s-2000-8466
73 https://doi.org/10.1086/321262
74 https://doi.org/10.1097/00004703-200312000-00003
75 https://doi.org/10.1289/ehp.00108s3401
76 https://doi.org/10.1542/peds.108.5.1155
77 https://doi.org/10.1542/peds.113.2.259
78 schema:url https://clinicaltrials.gov/show/NCT00273650
79 sgo:license sg:explorer/license/
80 sgo:sdDataset clinical_trials
81 rdf:type schema:MedicalStudy
82 Nb80c361c65ce4bb992ae392fd3ae18e4 schema:name Springer Nature - SN SciGraph project
83 rdf:type schema:Organization
84 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
85 rdf:type schema:DefinedTerm
86 sg:pub.10.1007/s10803-004-2549-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032339104
87 https://doi.org/10.1007/s10803-004-2549-6
88 rdf:type schema:CreativeWork
89 sg:pub.10.1097/00125817-200209000-00013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049523611
90 https://doi.org/10.1097/00125817-200209000-00013
91 rdf:type schema:CreativeWork
92 sg:pub.10.1385/mn:28:1:1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002335812
93 https://doi.org/10.1385/mn:28:1:1
94 rdf:type schema:CreativeWork
95 https://app.dimensions.ai/details/publication/pub.1075245451 schema:CreativeWork
96 https://doi.org/10.1001/jama.289.1.49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053720106
97 rdf:type schema:CreativeWork
98 https://doi.org/10.1006/bbrc.1999.0696 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007204574
99 rdf:type schema:CreativeWork
100 https://doi.org/10.1016/j.ridd.2004.09.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037628793
101 rdf:type schema:CreativeWork
102 https://doi.org/10.1016/s0002-7138(09)60225-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047880200
103 rdf:type schema:CreativeWork
104 https://doi.org/10.1016/s0009-8981(03)00119-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003671531
105 rdf:type schema:CreativeWork
106 https://doi.org/10.1016/s0165-1781(03)00200-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037342731
107 rdf:type schema:CreativeWork
108 https://doi.org/10.1046/j.1432-1327.2000.01595.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011567592
109 rdf:type schema:CreativeWork
110 https://doi.org/10.1054/plef.2002.0439 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001238276
111 rdf:type schema:CreativeWork
112 https://doi.org/10.1055/s-2000-8466 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057404548
113 rdf:type schema:CreativeWork
114 https://doi.org/10.1086/321262 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058623432
115 rdf:type schema:CreativeWork
116 https://doi.org/10.1097/00004703-200312000-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001210734
117 rdf:type schema:CreativeWork
118 https://doi.org/10.1289/ehp.00108s3401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064737166
119 rdf:type schema:CreativeWork
120 https://doi.org/10.1542/peds.108.5.1155 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067821287
121 rdf:type schema:CreativeWork
122 https://doi.org/10.1542/peds.113.2.259 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067822486
123 rdf:type schema:CreativeWork
124 https://www.grid.ac/institutes/grid.27860.3b schema:Organization
 




Preview window. Press ESC to close (or click here)


...